Michael J. Farrell - Nov 13, 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Stock symbol
RMD
Transactions as of
Nov 13, 2023
Transactions value $
-$1,213,694
Form type
4
Date filed
11/15/2023, 08:07 PM
Previous filing
Oct 17, 2023
Next filing
Nov 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Tax liability -$464K -3.23K -0.72% $143.60 446K Nov 13, 2023 Direct F1
transaction RMD ResMed Common Stock Tax liability -$436K -3.04K -0.68% $143.60 443K Nov 13, 2023 Direct F2
transaction RMD ResMed Common Stock Tax liability -$313K -2.18K -0.49% $143.60 441K Nov 13, 2023 Direct F3, F4
holding RMD ResMed Common Stock 0 Nov 13, 2023 Lisette and Michael Farrell Foundation
holding RMD ResMed Common Stock 4.09K Nov 13, 2023 Lisette and Michael Farrell Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/19/2020.
F2 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021.
F3 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
F4 Includes 78.152 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan.